Zoladex

Active Ingredient(s): Goserelin
FDA Approved: * December 29, 1989
Pharm Company: * ASTRAZENECA
Category: Cancer

* This drug may consist of multiple approval dates, manufacturers, or distributors. If applicable, they would be listed below under "NDC Database Records".

Zoladex Overview

Goserelin, sold under the brand name Zoladex among others, is a medication which is used to suppress production of the sex hormones (testosterone and estrogen), particularly in the treatment of breast and prostate cancer.[1][2] It is an injectable gonadotropin releasing hormone agonist (GnRH agonist). Structurally, it is a decapeptide. It is the natural GnRH decapeptide with two substitutions to inhibit rapid degradation. Goserelin stimulates the production of ...

Read more Zoladex Details
Details May Include Instructions, Side Effects, Interactions, Etc. Drug monograph is from Wikipedia. All text is available under the terms of the GFDL (GNU Free Documentation License). Source: en.wikipedia.org/wiki/Goserelin

Recent Zoladex Forums:

Be the first to start a discussion about this drug.

Possible Dosages for this and Related Drugs:

Goserelin

Implant: 10.8mg, 3.6mg
Insert: 10.8mg, 3.6mg
Insert, Extended Release: 10.8mg, 3.6mg

Note: Above list includes dosages for all drugs with the same combination of active ingredients.

NDC Database Records for Zoladex: (5 results)

Sorted by National Drug Code

0310-0950 Zoladex 3.6 mg/1 Subcutaneous Implant by Astrazeneca Pharmaceuticals Lp
0310-0951 Zoladex 10.8 mg/1 Subcutaneous Implant by Astrazeneca Pharmaceuticals Lp
50090-2027 Zoladex 3.6 mg Subcutaneous Implant by A-s Medication Solutions
70720-950 Zoladex 3.6 mg Subcutaneous Implant by Tersera Therapeutics LLC
70720-951 Zoladex 10.8 mg Subcutaneous Implant by Tersera Therapeutics LLC

Other drugs which contain Goserelin or a similar ingredient: (1 result)

GOSERELIN 1 discussion